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1. Introduction   
Mammography screening is now a well-established measure aimed at reducing mortality 
from breast cancer. However, while it is well established it is not without contention. 
Mammography screening has been the subject of fierce scientific debate about the evidence 
gathered using large scientific trials. There continues to be debate about the magnitude of 
benefit, issues of over-diagnosis, and the age at which screening should begin. These 
debates spill over into the policy arena where governments must decide which health 
measures to promote (and to fund).  It is remarkable that policies about mammography 
screening differ between and within countries. This is particularly the case for policies 
establishing the age at which women should commence screening and the recommended 
interval between screening. Any policy decision about frequency of screening and lowering 
the age limit has resource implications and these must be weighed against the potential for 
benefit.  
This chapter presents an international overview of the differing policy contexts in 
countries with mammography screening programs. It then explores the intersections 
between scientific knowledge, policy making and individual decision making with 
particular reference to the age at which screening should begin. Using research conducted 
with women in three different policy settings (two in Australian states and one in a 
Swedish county), it explores the differing ideas that form a crucial part of women’s 
decisions to participate in screening. While most research focuses on women who don’t 
participate in screening (there is a vast literature about the ‘underutilisation’ of 
mammography screening), we can learn much about health behaviour by talking with 
women who have chosen to be screened. This is particularly the case where screening is 
contentious.  
The research at each of the sites comprised qualitative interviews with women aged 40-49 
years who had participated in screening. Interestingly, the risk of breast cancer is not the 
main reason that women choose to be screened. For women in rural Uppsala, Sweden, trust 
in authorities was the dominant discourse; for women in rural Victoria, discourses of rights 
and choice predominated; and for women in rural Tasmania, trust in technology was a key 
reason for participating in screening. Women in rural areas also utilise services that are 
delivered in their local area because they highly value regional health services. These ideas 
are necessarily bound up in sociological concepts of choice, trust and risk. An 
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understanding of these differing ways that women in different policy settings view the 
‘invitation to be screened’ is an essential part of exploring what information women should 
receive about screening, and how they will respond to the provision of screening services. 
2. The intersections between scientific and policy knowledge 
In western developed countries, policies to reduce the mortality (and morbidity) from 
cancer have become a national health priority. Breast cancer is a major cause of mortality for 
women in many such countries, and the quest to reduce breast cancer mortality has seen 
early detection emerge as the leading policy strategy. The scientific evidence supporting 
early detection in the form of mammography screening is viewed as being strong – 
however, it is also contentious. The translation of scientific knowledge into public health 
policy is never a simple process, but this is all the more difficult when there is general 
agreement around the principle of early detection, but disagreement about factors such as 
the age at which screening should commence and screening intervals. The ‘story’ of the 
evidence surrounding mammography screening is quite well known. However, as is 
illustrated in the following re-cap of this story, scientific evidence alone doesn’t provide all 
the required knowledge for successful policy implementation. 
Randomised controlled trials are studies where the efficacy of an intervention is judged 
following random allocation of study participants into a study group that receives the 
intervention and a control group that does not receive the intervention. At the end of a 
specified period of time the results are compared. Evidence from such trials is regarded as 
‘the most scientifically rigorous method of hypothesis testing available in epidemiology’ 
(Last, 1995: 140). Eight randomised controlled trials of mammography screening were 
conducted in the United States, the United Kingdom, Sweden, and Canada. The earliest of 
the trials was the Health Insurance Plan (HIP) of New York which was conducted in the 
1960s (Shapiro et al., 1982). This was followed by Swedish trials commencing in the late 
1970s and early 1980s: Malmö (Andersson et al., 1988), Two County (Tabár et al., 1985) and 
Stockholm (Frisell et al., 1991). At approximately the same time, a randomised controlled 
trial arm of the broader United Kingdom screening research commenced in Edinburgh 
(Roberts et al., 1990). Trials have been also been conducted in Canada (Miller et al., 1992a; 
1992b), and Gothenberg in Sweden (Bjurstam et al., 1997). A trial in the United Kingdom 
from 1991 to 1997 aimed to identify the evidence of benefit for women below the age of 50 
found a reduction of 17%, but this was not statistically significant (Baines, 2011). Proponents 
of screening mammography cite evidence from these trials that mass mammography 
screening as a population-based strategy reduces mortality from breast cancer by 
approximately 30% for women aged 50–74 years.  
These findings have formed the scientific justification for breast cancer screening programs. 
The Australian policy setting can be used to illustrate the use of scientific policy and the 
broader political concerns that contribute to government decisions to establish a screening 
program. In the lead up to the introduction of the Australian screening program, the 
Screening Evaluation Coordination Unit (SECU) at the Australian Institute of Health 
conducted a review of the overseas evidence and reported to the Australian government on 
the feasibility of establishing a national breast cancer screening program (Australian Health 
Ministers’ Advisory Council, Breast Cancer Screening Evaluation Screening Committee, 
1990). In examining the scientific evidence, the SECU unit focused on the HIP and the Two 
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County trials as providing evidence of benefit. It also took into account other non-
randomised trials that also showed a benefit from screening and included a discussion of 
the Malmö and United Kingdom (Edinburgh) trials which had not achieved statistical 
significance but had reported the potential for benefit from mass screening. Based on all the 
evidence considered, the SECU predicted that with a 70% participation rate in the targeted 
age group, the reduction in mortality from breast cancer would be around 16% (noting that 
this figure included non-participants and those outside the targeted age group) (Australian 
Health Ministers’ Advisory Council, Breast Cancer Screening Evaluation Screening 
Committee, 1990: 26). The Australian policy documents reflect this claim by stating that an 
organised national screening program will result in a significant reduction in breast cancer 
mortality (National Advisory Committee for the Early Detection of Breast Cancer, 1992).  
This review of scientific evidence was accompanied by feasibility research aimed at 
understanding issues associated with policy implementation. Feasibility studies, often in the 
form of pilot screening programs, were conducted in the five most populous Australian 
States. These pilot programs were aimed at applying the Australian context to the 
application of the selected scientific knowledge. Issues examined included strategies for 
encouraging women to participate in screening, psycho-social issues in implementation, 
analysis of the costs of screening, and technical aspects of service delivery.  
Within the broader policy context in Australia, funding concerns also contributed to the 
need for a nationally organised program. The national universal health insurance program, 
Medicare, covered payments for diagnostic mammography for the relatively small number 
of symptomatic women (women with breast lumps or other potential signs of breast 
disease). However there was the perception that, increasingly, asymptomatic women were 
seeking to have mammograms. This blurring of the distinction between diagnostic and 
screening mammography (a population-wide program for well women) had the potential 
for a ‘blow-out’ of costs due to increased de facto screening mammography. Duckett (a 
former senior health bureaucrat and, from 1994 to 1996, secretary of the then Australian 
Department of Human Services and Health) points to the two aims of the mammography 
program: ‘In addition to the health enhancement objective of promoting early detection of 
cancer and thus reducing breast cancer mortality, this program had the objective of 
moderating the previous rapid growth in expenditure on mammography’ (1999: 81). 
Therefore, the decision to implement the screening policy seemed to bring together 
advocates arguing for the efficacy of reducing mortality from breast cancer, those 
establishing the feasibility of the programmatic aspects, as well as health bureaucrats 
concerned with expenditure.  
Population based screening, however, is not without its critics. Since the incidence of the 
disease is much lower than in a diagnostic population, such screening programs require large 
numbers of well people to participate, in order to demonstrate effectiveness. For most people 
who participate in the mammography screening program, there will be no benefit, in terms of 
reduced morbidity or mortality. In a radio interview, one health bureaucrat encapsulated this 
aspect of screening programs by stating: ‘It is a community action rather than an individual 
action and we can never, ever say to women that as individuals they individually will benefit’ 
(Australian Broadcasting Corporation, 1998). In fact, at an individual level, for some women 
the outcome will be worse. The possibility of having a ‘false negative’ test result may mean 
that women are falsely reassured about the absence of breast cancer, a ‘false positive’ test 
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result may subject women to a series of further tests, and the uncertainty resulting from 
indicators of benign breast disease may mean that treatment which is unwarranted will be 
recommended. Foster points out that, as a secondary prevention program, ‘breast cancer 
screening cannot prevent breast cancer, nor can it promise a cure; it is rather an attempt to gain 
better control over the disease’ (Foster, 1995: 116).  
In addition to the criticism of the potential harm of screening as a population based strategy, 
there has been criticism calling into question the epidemiological evidence of benefit (for 
example, Schmidt, 1990). From the commencement of the promising reports about the 
possibilities of mammography, Dr Petr Skrabanek, a senior lecturer in community medicine at 
Trinity College in Ireland, maintained that the reduction in mortality was a substantial over-
estimate of the evidence (Skrabanek, 1985). Dr Maureen Roberts (1989), who established the 
Edinburgh mammography program, argued that screening had not delivered the promised 
benefits in an article in the British Medical Journal published shortly after her death from breast 
cancer. More recently, following the Canadian study results, critics have focused on the lack of 
mortality benefit, the potential harm for women from the program in terms of over-diagnosis, 
and issues associated with screening asymptomatic, well women who have no breast 
problems. They claim that ‘although politically attractive, the benefits of mass population 
screening, even in older women, are too small and the harm and cost generated too great to 
justify widespread implementation of screening mammography as a publicly funded health 
measure’ (Wright & Mueller, 1995: 31). Further, in 1999, there was extensive media coverage in 
Sweden raising questions about the evidence from the trials, together with claims that the 
programs that have been implemented have not delivered the promised mortality benefits 
(Atterstam, 1999; Sjönell & Ståhle, 1999a; Gøtsche & Olsen, 2000). These critical voices, 
however, are not part of a vigorous and public debate about the efficacy of screening 
programs, rather emerging publicly only occasionally and generally dismissed by the central 
proponents of screening as ‘ill informed’, even endangering women’s lives. As noted by 
Atterstam, the space for a critical point of view is minimal (1999: 1). 
Ongoing debate has existed about the scientific evidence for screening women aged between 
40 and 49 years. More recently, studies have attempted to ascertain the magnitude of 
benefit, but these results are contested. Commentary, dispute and refutation of claims from 
the Canadian trials that, in 1992, resulted in a questioning of benefit of population-based 
mammography screening continues ferociously almost 20 years later (Baines, 2011). The 
level of dispute also reveals the entrenched positions that various experts and commentators 
occupy in their reading of the scientific results from the trials. A recent review by Fletcher 
(2011) problematizes the changed landscape of screening, arguing that while it had its place 
as a secondary prevention measure, it is an ‘imperfect tool’ and that with progress in 
primary prevention and treatment, the need for screening should decrease. Such a message 
may be difficult to reconcile with the ‘early detection is your best protection’ message that 
forms part of the dominant discourse about breast cancer screening. That policies rest on 
dominant beliefs and often imperfect and uncertain science is evident when policies for 
breast cancer screening are explored. 
3. Policy implementation and policy settings – an international overview 
In arguing that policy is an ongoing process, rather than a finite event, Considine says, 
‘policy is the continuing work done by groups of policy actors who use available public 
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institutions to articulate and express the things they value’ (1994: 4). Understanding policy 
choices relating to mammography screening involves more than identifying who benefits 
and who loses. It is about understanding the dominant ways of thinking about an issue, the 
cultural dimensions of the issue, and whether policy players have their voices heard, or are 
excluded from the debate. Health policy is a broad area. In intervening in health at a policy 
level, governments are called on to undertake a variety of tasks relating to health financing 
for medical and hospital systems, as well as undertaking measures to redress health 
inequalities. Increasingly, governments are required to ensure provision for expensive high 
technologies in health and put in place programs to protect health. Texts analysing the 
politics of health and health policy portray the health system as complex, resource intensive 
and a site of much political contestation in the formal political arena (see, for example, 
Palmer & Short, 2010). 
Palmer and Short claim that health policy is distinctive in three significant ways: first, the 
role of the dominant profession – the medical profession – in shaping policy direction is 
unprecedented in comparison to other policy areas; second, consumers are confronted 
with a complex arena of services where it is difficult to distinguish between ‘good’ and 
bad’ services; and, third, the nature of health care means that decision making is often 
associated with life and death issues and, therefore, is psychologically stressful. This leads 
‘the community to see health care and its providers as being “different” (2010: 25). 
Accompanying this latter perception is the implicit assumption that consumers can trust 
health care providers, that governments will provide effective and efficient health care 
and that health care policies and innovations will have a sound basis in scientific research. 
This is particularly the case with policies involving technologies. However, the 
relationship between health care provision and research evidence is not clear cut (Davis & 
Howden-Chapmen, 1996). 
As can be seen from the outline of evidence in the previous section, consensus about the 
evidence is widespread but not universal. Leaving aside the question of whether screening 
should be implemented at all, the lack of universal consensus is particularly important when 
governments and health authorities are deciding who they should be screening (i.e., the age 
at which screening should begin) and what the screening interval should be. These decisions 
are made combining a range of factors: resource implications and who should pay (it is 
more costly to extend the target group and to screen at shorter intervals); political 
implications (whether professional or consumer groups are demanding availability and 
access to services; where decision making fits within an election cycle); implementation 
implications including the structure of governance for health services and health workforce 
availability; geographical considerations; and how to access the target population groups – 
in particular whether active strategies for recruitment can be used or whether women are 
encouraged to self select into the screening program.  
In addition to the issues identified above governance of a population based health program 
will affect the claims that can be made about its effectiveness in meeting targets. In many 
jurisdictions in western countries, two tiers of government are involved in policy direction 
and implementation. The roles that different levels of governments play in screening 
programs are diverse, with many devolving responsibility from a national government to 
state or county governments (BreastScreen Australia Evaluation, 2009). Thus, while the 
screening policy is decided at the national level, operational responsibility for the programs 
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is devolved to levels of government such as states, territories, provinces or counties. This is 
particularly important to note in countries like Australia and Sweden where populations in 
various jurisdictions are low and may be dispersed. With different operational procedures, 
guidelines and recruitment strategies existing within countries, there is a risk of variation in 
population coverage, thus diminishing the capacity of the program to demonstrate overall 
population level benefits. In some countries, private providers coexist alongside the state 
services that are provided. Again, this has implications for determining policy parameters 
(such as eligibility and recruitment) as well as the determination of effectiveness.  
In order to explore the differences in policy settings a desk top search was undertaken. It 
draws on two main sources – the international review of selected policy settings carried out 
by Australian policy makers (BreastScreen Australia Evaluation, 2009) (based primarily on 
stakeholder interviews) and the information provided by participating countries to the 
International Cancer Screening Network (2010) where English was available. In addition to 
the information provided, reports or publications of specific network members were 
downloaded, and further searching was undertaken where information was unclear (either 
by corresponding with member countries, further searching on participating country health 
websites, or through the academic literature). What emerges is a picture of considerable 
complexity. While generally established as government public health initiatives, there is a 
combination of public and private providers. The private sector plays a role in screening in a 
number of countries, with sole responsibility for parts of countries such as England and 
New Zealand. Objectives for participation are generally set at a national level (generally 70% 
of the total population, but 80% in England) with regions or specific services having 
operational responsibility. This brief description of the selected policy settings, with 
particular emphasis on the age at which screening is recommended or available, and where 
the information is available, the strategies for recruitment, highlights the differences in 
approach that exist both within and between different countries  
Australia 
Australia has a national government that determines policy but operational responsibility 
for service delivery is devolved to State/Territory governments. Screening is free of charge 
for women attending through the national program. In most (but not all) States/Territories, 
women aged 50-69 years are invited to attend screening at 2 year intervals. Invitations are 
based on the electoral roll (elections are compulsory in Australia); where access to the 
electoral roll is not possible, women are encouraged to attend for screening through 
advertising. In 2004-05, the participation rate for women in the 50-69 years target group was 
56.2% (with variation between Australian states) (Australian Institute of Health and 
Welfare, 2008). Women aged 40-49 years can attend for screening, but whether, having 
attended, they will be invited back at 2 year intervals varies between individual states. 
Canada  
The Public Health Agency oversees the Canadian Breast Cancer Screening Initiative (Public 
Health Agency of Canada, 2008), but has less of a leadership role than other countries where 
national governments establish programs and devolve operational responsibility. 
Responsibility for mammography programs is devolved to the 12 Provinces/Territories, all 
of whom provide screening for women aged 50-69 years every two years. It is estimated that 
approximately 60% of women aged 50-69 years age group have had at least one 
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mammogram (Hanson et al., 2009). All but three Provinces/Territories allow women to 
access the program from age 40 years. All programs allow women aged over 70 years to be 
screened. A range of strategies are used to invite women to participate – letters of invitation, 
media campaigns and referral from medical doctors. Policy documents indicate a reliance on 
doctors referring those women outside of the eligible age groups. In five of the 
Provinces/Territories, women aged 40-49 years are reinvited for screening on an annual 
basis; the remainder do not reinvite women in this age group. 
England 
England has a nationally coordinated screening program, but screening services are 
devolved to individual screening units in National Health Service (NHS) regions. Women 
aged 50-70 years are invited to attend and in 2004-05 overall 75% of women invited to 
screening attended (NHS, 2006). The invitations are based on general practice registers. 
Women are screened at three year intervals. Women aged over 70 years are able to continue 
to participate in the program if they wish to do so. From 2012, following the ‘Age Trial’ 
(Moss et al., 2006), that investigated the age at which screening should commence, women 
will be invited to attend screening from age 47 years. 
Finland 
Finland has a unitary government that provides an organised screening program based on a 
national population register. The target age group is 50-69 years and women are invited to 
attend screening when they turn age 50 years of age. In Finland there has been debate about 
the age range for mammography screening. Initially women aged 50-59 years received 
regular invitations to screening, and women aged 60-69 received ‘irregular’ invitations 
(depending on the municipality); from 2007 all women aged 50-69 have been invited to the 
free screening program. Participation in screening by the target population is very high, 
with 87.9% of women invited to screening in the past three years having participated 
(Palencia et al, 2010). 
Ireland 
In Northern Ireland women aged 50-70 years are invited to attend the screening program every 
three years. In the Republic of Ireland, women aged 50-69 years are invited every two years. Both 
programs are free. The register of eligible women is compiled using government and private 
health sources in addition to individual women registering. There is approximately a 73-75% 
acceptance of screening invitations in both Northern Ireland and the Republic of Ireland (Kinnear 
et al, 2010). Screening is provided via mobile and fixed site services. 
Italy 
With guidelines set at the national level, Italian mammography programs invite women 
aged 50-69 years to screening. The mammography programs are devolved to the 21 
geographical regions and there are a total of 130 screening programs – 64 in the North, 39 in 
the Centre and 27 in the South and Islands. Some programs include women aged over 70 
years.  Since the commencement of screening programs some facilities include women aged 
45-49 years as the national government has provided free biennial mammography for 
women in this age group.  There are large differences in population participation between 
the regions, partially attributed to the fact that some programs in the Central and Southern 
regions have only recently been established, and due to dispersed populations some regions 
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struggle to provide a biennial service to all women in the target age groups (Georgi et al., 
2009). 
Netherlands 
Mammography is provided for all women aged 50-75 years of age. Women outside this age 
group may still access mammography, but the out-of-pocket expenses to do so will depend 
on their health insurance arrangements (all citizens are required to have health insurance). 
Approximately 84% of women invited to screening attend (Palencia et al, 2010). 
New Zealand 
Women aged 45-69 years are eligible to participate in screening in New Zealand, although 
the publicity materials emphasise that the greatest benefit is for women aged 50-69 years. 
For the two years up to December 2006, 60% of women aged 50-64 years had participated in 
screening, below the target of 70% and with high variation in participation between 
population groups (Thomson, Crengle & Lawrenson, 2009). Service delivery is devolved to 
eight regionally based lead providers, with funding responsibility the role of the central 
government. The private sector plays a key role in providing services. Women register for 
screening by phone or online. In some areas women are identified through general practice 
registers and are invited to screening. 
Norway 
Women aged 50-69 years are invited to be screened every two years. There are 26 stationary 
and 4 mobile screening units. The Central Population Registry of Norway is used to identify 
eligible women. Invitations are mailed to each eligible woman, suggesting a time for an 
appointment. Approximately 77% of all women invited participate do so (Kalager, et al, 
2010).  
Sweden 
Sweden’s central government has established mammography screening with delivery of 
mammography programs devolved to the 20 counties. While the two year screening interval 
is consistently applied, counties vary in whether women aged 40-49 years can access the 
program. The majority of counties invite women aged between 40-74 years to screening; six 
provinces invite women aged 50-69 years, and in a few cases the age range is slightly 
different again. Eligibility is based on the national population register. Screening is low cost, 
with women making a small co-payment for the service. The participation rate for women 
invited to screening is approximately 80% (Palencia et al, 2010). 
United States of America 
Guidelines for mammography screening in the Unites States of America emphasise the 
importance of clinical breast examination as well as mammography screening. While the 
Food and Drug Administration sets standards for mammography facilities, arrangements 
for screening are indicative of the health system more generally – where insurance coverage 
dictates recruitment and participation, and there is no organised national program beyond 
the setting of quality standards and guidelines for women. The United States Preventive 
TaskForce (2009) recommends mammography screening for women each two years 
commencing at age 50 years. Like the Australian policy context, the Taskforce emphasises 
that the decision to be screened between ages 40-49 years is an individual woman’s decision 
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and should be made taking account of personal beliefs about the benefits and harms. 
Various other stakeholders disagree with this advice and recommend screening from age 40 
years. Women participate in screening through their health maintenance or health insurance 
organisations (although most states mandate that insurance companies reimburse all or part 
of the cost of mammography for their members). Uninsured and low income women aged 
over 40 years who qualify for Medicare health insurance are able to access a screening 
mammogram each year (with eligibility for a baseline mammogram between 35-39 years) 
(National Cancer Institute, 2010).  
The selected international cases highlight the differences in policy in different health care 
settings. What is surprising is the level of scientific contention around the evidence 
particularly in relation to the magnitude of benefit for aged under 50 years. This plays out in 
differences within policy settings about women’s participation in mammography screening. 
This is illustrated more clearly in the following section which reports on interview studies 
with women in three different policy settings who chose to participate in mammography 
screening.  
4. Women’s choice to be screened – different policy settings, different 
choices? 
As previously stated, the age at which screening begins is a key site of policy difference, 
with the links between scientific evidence and policy knowledge unclear. The rest of this 
chapter focuses on this issue and explores the perspective of those women in different policy 
settings who have participated in screening programs while aged between 40-49 years. The 
aim is to highlight how embedded the policy context is in shaping what appears to be 
individual behaviour. Three policy settings have been chosen because their policy context 
differs for women aged 40-49 years. These three settings are two states in Australia and one 
county in Sweden. The first site is Tasmania. This island state is geographically isolated 
from the rest of Australia. It is a decentralised state. Of a total population of approximately 
476,000 people, approximately 60% live outside the capital city of Hobart. The second site is 
the state of Victoria. Less decentralised than Tasmania, it has a population of 5.1 million 
people with 3.7 million people living in the capital city of Melbourne, but an extensive 
regional and rural hinterland that comprises 1.4 million people. The third site is Uppsala, 
Sweden. With a total population of approximately 336,000 people, Uppsala is also quite 
decentralised, with 40% of the population residing outside its major municipality. 
The key difference between policy settings in Australia is whether they re-invite women in 
the 40-49 year age group once women have chosen to attend. As stated earlier, the 
Australian policy on screening targets women aged 50-69 years but allows women aged 40-
49 years to make an individual decision about whether to participate in screening. Tasmania 
has a policy of reinviting women once they have attended once. In the more populous state 
of Victoria, women are not reinvited – rather they must make the decision themselves as to 
whether they continue to participate in screening while they are in the 40-49 year age group. 
Another key difference between these two states, relates to jurisdictional issues. Health 
providers in Tasmania are unable to access the electoral roll to call women to screening once 
they turn 50 years of age, relying on public information campaigns to encourage women to 
participate, whereas Victoria recruits women using the electoral roll. In both Tasmania and 
Victoria, mammogram facilities are provided both at fixed sites and through mobile services 
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to rural areas. By contrast, the Swedish county of Uppsala actively invites women to 
screening at age 40 years, with a recruitment letter giving an appointment date and time for 
individual women to attend.  
Of particular interest in this study was the decision making that rural women participated in 
when they decided to have a mammogram when aged 40-49 years. Rurality has been linked 
with poorer health outcomes and a key concern to policy makers in decentralised countries 
is how to best serve small populations in rural areas (Palmer and Short, 2010: 274). In each of 
the three policy settings examined, an emphasis has been placed on encouraging rural 
women’s access either through mobile services (Tasmania and Victoria) or by locating 
mammography at smaller regional centres (Uppsala). Exploratory research in Tasmania 
found that screening rates in the 40-49 year age group were substantially above those 
estimated by BreastScreen Australia and in the Victorian setting were significantly lower. 
This indicates that perhaps some other factors related to rurality and the provision of 
services might be important in understanding women’s decisions about mammography.  
In order to examine women’s decision making about mammography screening in these 
three different contexts, a qualitative study was designed. Using an interpretive 
methodological approach and a purposive sampling strategy, semi-structured interviews 
were conducted with women who had participated in mammography screening between 
the ages of 40-49 years. The interview schedule was in four sections. First, demographic 
information was obtained. Women were then asked about their ideas about health generally 
– the importance of health, and whether they took steps to maintain health. They were then 
asked about their screening history, their reasons for choosing to be screened, their ideas 
about mammography screening and their knowledge of contemporary debates about the 
age at which screening should commence. Finally, they were presented with some 
statements about mammography screening and asked whether they agreed or disagreed 
with them. These Likert questions were derived from the exploratory study originally 
carried out with women in the Tasmanian site (Willis and Baxter, 2003). While all questions 
(apart from the Likert scale questions) were open-ended enabling participants to reveal as 
much or as little as they wished, the schedule was designed to elicit responses from the 
broad ideas about health to specific information about their screening experiences. Where 
answers were unclear, additional probing questions were asked.  
The interviews were audiotaped and transcribed verbatim. Analysis commenced with 
transcription of the first interview, ensuring that interviews were flexible enough to capture 
the important issues at each site. This was particularly important for those interviews 
carried out in Uppsala (see below). In both the Australian settings, the Chief Investigator 
interviewed all participants. In the Swedish study, the process differed a little because of the 
reliance on a Swedish interviewer (five interviews were conducted in English) and 
translation into English. This required attention to the ways that words and phrases are 
given meaning in the Swedish cultural context and how they could be best understood in 
English. 
Interviews were analysed using a thematic analytical approach that incorporated both 
inductive and deductive elements. As the interview schedule had specific questions 
(outlined above), themes relating to reasons for attending were initially deductively derived 
from the data, but the contextual information presented by participants then allowed 
inductive exploration of these themes. Following transcription, each transcript was read, re-
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read and sections coded. Transcripts were then compared to find similarities and differences 
between responses. This then enabled the sorting of responses into categories. Further 
immersion in the data enabled the identification of themes relating to social and cultural 
ideas about knowledge and trust. 
Ethics approval for the study was obtained from the Human Research Ethics Committee, 
University of Tasmania for the Tasmanian and Victorian cohorts and the Research Ethics 
Committee, Uppsala University for the Swedish cohort. 
Study Site 1: Tasmania, Australia 
This research was informed by findings from a pilot study of 14 women in small rural sites 
on the east coast of Tasmania (Willis and Baxter, 2003). The Tasmanian cohort comprised 22 
women located at four small rural sites on the north west coast of Tasmania - a 
geographically isolated area of Tasmania. These small geographic locations are serviced 
each two years by a mobile breast screening service. Women were recruited to the study 
through advertising in local newspapers and posters at local health centres. Characteristics 
of the women who chose to participate in this study have been reported elsewhere (Willis, 
2004). Women were aged between 43 and 52 years at the time of the interview. All had 
participated in screening prior to turning 50 years of age. All but four had been re-screened 
at least once. Of the four who had not been re-screened, two had decided against screening 
at least until they were age 50, one was not due to be re-screened, and one was currently 
unable to access the problem as she was receiving treatment for breast cancer (detected 
through the screening program).  
In exploring the key reasons for deciding to be screened, participants were categorised into 
two groups, each with equal numbers. Women in the first group were characterised as ‘high 
risk/high fear’. They perceived they were at elevated risk of breast cancer and this was a 
key factor in choosing to participate in mammography screening. Five participants believed 
this was the case because they had ‘cancer in the family’, five other participants had a 
previous history of benign breast conditions and saw themselves as higher risk of breast 
cancer, and one participant was included in this group because she was ‘just terrified of 
getting breast cancer’. 
The second group were those participants characterised as ‘low risk/low fear’. This group of 
women saw themselves as having low or no risk of breast cancer but believed it was 
important to take advantage of the screening service anyway. They were most likely to see 
the service as providing an important health opportunity and it was their responsibility to 
take advantage of it. The opportunistic decision can be encapsulated in this quote:  
Well, its a free test and I might as well use it. I’ll do anything if its concerned with health ... I thought 
I might as well get in early. 
Participants in this ‘low risk/low fear’ group did not see themselves as at high risk of 
getting cancer. In fact many of them stated that they didn’t think they would ever get 
cancer. However, they argued that it was important to take any precaution that was 
available to them. For some, screening was a way of ‘exercising control’ over their health.  
Across both groups two key themes were important. These were the high level of ‘trust in 
technology’ and the notion of ‘individual responsibility’. Inherent in this latter theme was 
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the importance of having ‘good health habits’ with mammography being seen as something 
that should become a health habit in taking responsibility for health and wellbeing.  
In indicating a high level of trust in technology, some women drew on their lack of 
confidence in their capacity to perform breast self examination, and this was a factor in 
deciding to participate in screening. Having a test and using technology were presented as 
unproblematic and, generally, certain ways of defining one’s health status. The view of 
technology and testing that is portrayed through these interviews is of a benign test with the 
main benefit of confirming one’s healthy state. Only three of the participants discussed 
whether the technology could be fallible. Participants indicated that they had a high level of 
trust in the technology as a means by which they could obtain reassurance and confirmation 
of their good health. As one participant said: 
The good thing about having the mammogram is that its reassuring. It tells us of any change, if its 
fine, you know its fine... I never think of it as having a down-side because the results are too 
important  
Even where participants reflected on the possibility of having additional testing due to a 
false positive mammography result, the prevailing view was that such testing was essential 
in the process of confirming one’s healthy state. 
Participants also saw themselves as taking responsibility for their health. They saw the 
choice to be screened as part of their ‘good health practices’ that were important indicators 
that they were taking care of themself. Mammography co-existed with a range of practices 
they engaged in, from their annual check up with their general practitioner, to ensuring that 
they got sufficient exercise and had a healthy diet, to low levels of ‘risk behaviours’ such as 
smoking or excessive alcohol consumption. They thus saw themselves as engaging in a 
‘good health habit’ and that it was important to get into this habit before the age of 50. 
Participants believed that they were more in tune with their bodies at a younger age, and 
that it would be more difficult to ‘get into the habit’ once they were older. If it was a routine 
aspect of their health care that was entrenched in their health practices, this was seen as 
beneficial. For example: 
I thought, I’ll get started now and it won’t be so scary when I am 50... Yes, getting myself into the 
habit so that once I was 50 at least I was already in that habit, it wasn’t something that I had to 
consciously take that other decision and another step to go along. 
It’s good to get into a routine ... Because it means it becomes a part of your life, rather than just 
something you remember maybe three years later ... it becomes a routine, it becomes part of your life. 
It’s a safety net, I suppose.  
In discussing why they had chosen to be screened even though the target group was from 
age 50-69 years, participants discussed their belief that there was an increased number of 
younger women getting cancer, and that the age limit should be lowered. Indeed, what they 
perceived as the arbitrary nature of the age limit also meant that they should be able to 
exercise choice. Participants emphasised the importance of ‘making up their own minds’ 
about participation.  
It depends whose opinion you listen to ... I’ll just follow my own thoughts... Its a service thats there 
for me every two years and I am not interested in different opinions and different flavours of the day 
because of the changes on a weekly basis... I suppose the chance of women over 50 getting cancer [is 
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higher] ... I don’t know what they base their figures on. Women younger than that are getting breast 
cancer. So I don’t know whether they should have an age. I think they should make it free for all if you 
want to have the screening done. That’s the service there for you irrespective of your age and it should 
be free. 
Study Site 2: Victoria, Australia 
The notion of choice in the decision to be screened has a different dimension for women in 
the state of Victoria. Because they are not re-invited once they have participated, women 
aged 40-49 years at this policy site must ‘re-make’ the decision to be screened each two years 
until they turn 50 years of age. The Victorian participants in this study comprised 28 women 
located at two regional sites in rural Victoria. The average participation rate for women in 
this age group choosing to attend for screening is low in comparison with the Tasmanian 
study sites (at the time of this study between 10% and 13%). Two regional sites where there 
were sufficient numbers of women to gain a diverse sample aged between 40-49 years who 
had participated in screening were identified. These regional centres were located 
approximately 100 kilometres from the capital city. Local media and health services were 
enlisted to advertise the project and women contacted the researcher directly if they wished 
to participate in the interview study.  
While most of the Tasmanian cohort emphasised choice and were opportunistic in their 
reasons for attending screening, differences in the Victorian cohort were readily apparent. 
With a much lower percentage of women in this age group attending for screening than the 
population centres in Tasmania, what emerged are clear reasons for concern about breast 
cancer and the need to exercise their right to be screened. That this was a political decision 
was evident in one participant’s account of seeing a poster advertising the mobile service for 
women aged 50 years and above and someone had crossed out 50 and replaced it with ‘40’, 
thus alerting her to the possibility that she could also attend.  
The two categories of risk perception and decision making found in the Tasmanian cohort 
did not adequately capture this more complex decision making in this policy context. Thus, 
in terms of primary reason for attending mammography screening there were four 
categories that encapsulate this initial decision.  
1. Opportunistic – similar to the low risk/low fear group in the Tasmanian cohort, six 
women described initially attending because the service was available and so they 
believed they should use it. Of these participants, 1 also participated because she was 
‘close in age to 50 years’ and one also discussed having a family member who had 
experienced a benign growth removed from her breast. While they had attended the 
screening service because it was available, these two participants also discussed these 
factors as contributing to their decision.  
2. Family history and fear of cancer – For seven women the fact that they had a ‘family 
history’ of cancer (not necessarily breast cancer) was the primary reason that they 
decided to attend for screening. This was the only group that perceived themselves as 
‘high risk’ of cancer themselves, and thus were similar to the ‘high risk/high fear group 
in the Tasmanian cohort. 
3. Having indirect experience of cancer through knowing a close friend who had 
experienced breast cancer prompted three women to attend for screening when it was 
available. They did not believe that they were at high risk of getting breast cancer, but 
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knowing someone who had experienced the disease heightened their awareness of the 
importance of screening tests such as mammography. 
4. The largest group were those who had previously had mammograms for diagnostic 
reasons. Twelve women had either had a prior history of benign breast conditions or 
they had other symptoms that had required a mammogram, and when the screening 
service was available in their region after these events, they took the opportunity to be 
screened while still in their 40s. Many women in this group had also participated in 
‘well women’s checks’ run by a private screening service at the capital city, and this had 
included mammography, so they had a high awareness of being screened for breast 
cancer. Most interestingly and in contrast to the Tasmanian participants, this group also 
did not perceive that they were at high risk of breast cancer, despite their having had 
previous breast problems. 
As with the Tasmanian participants, in this group there were also strong views about the 
power of technology. Mammography was viewed as preferable to breast self examination or 
a clinical examination by a medical professional. For example:  
I think the visual thing is more comforting and reassuring than someone doing a breast examination 
on you and saying you’re fine. That’s their opinion, but if its in an x-ray, you can actually see it and 
somebody’s looked at it, and if you’re give the all clear, well you think, that’s peace of mind.  
Just peace of mind, I suppose. It’s something that you can do quickly and cheaply and it lets you off 
the hook. You think, oh well, I’m OK, I’ve had that test done. I don’t need to bother doing the arm up 
behind my head [breast self examination].  
Reassurance and peace of mind were the key advantages of mammography discussed by 
participants. Almost all participants used these words to describe how they felt about 
mammography.  
With regard to policy differences (and the fact that the policy in Victoria required women to 
take responsibility each two years to participate in screening), participants generally 
believed that women should take responsibility for their health, but also added and ‘it 
would be nice to be notified’ when they were due for rescreening. With regard to women’s 
responsibility, illustrative statements include:  
Women should be interested enough in their own bodies to want to remember.  
I would imagine that women who are concerned about their health would at least make some sort of 
note of when they’d be due again and do it themselves without having to be reminded 
The complexity of a policy focused on age as defining eligibility was problematised by 
women. When asked if they knew why the screening program targeted women aged 50 
years and over, about half the group had some awareness of the links between cancer and 
age. Many, however, believed that cancer and age were not necessarily related, but that 
women of any age could get breast cancer. Moreover of those women who mentioned the 
links between cancer and age, some expressed some uncertainty about this link as it 
contradicted their experiential knowledge gained through local communities and the media. 
There was some discussion of media coverage of young celebrities who had breast cancer, 
contributing to the belief that breast cancer is also a young women’s disease. The ideas 
about age and risk were encapsulated in statements such as:  
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There is no firm statistic to say it is always over 50 years that you get breast cancer. I mean there are 
women in their 20s getting it. And age holds no barrier on this.  
It doesn’t have to be any particular age, it can be any age that you can get breast cancer. You can be 
in your 20s, 30s or 50s whatever… Breast cancer is something that can happen any time. 
But I still think it should be encouraged for women who are under 40 because I think that some of 
those ones…could have a problem picked up earlier. It might be too late by the time they’re 50. 
Study Site 3: Uppsala, Sweden 
The Swedish cohort comprised 32 women attending for screening at two rural sites in 
Uppsala. All women aged between 40-49 years who were scheduled to attend 
mammography screening at two decentralised centres in Uppsala county in a one week 
period in August 2003 were invited to participate in the study. Women were advised about 
the study with an additional insert in their recruitment to screening letter. Participants 
ranged in age from 40 to 50 years.  
Most women had attended mammography screening three or more times, some having 
attended prior turning 40 years of age (for diagnostic reasons). Four participants from one of 
the two sites were attending for the first time, having turned 40 years of age during the past 
year. Participants were asked their reason for attending. The key initial finding that relates 
to the policy context was that, unlike the two other settings, participants did not and could 
not discuss participation in mammography screening as a matter of choice. Hence the title of 
the main findings paper from this part of the study ‘I come because I was called’ (Willis, 
2008). This was, in essence, the reason why they had participated – the health authorities 
had called them to attend and they did so. Twenty-seven of the 32 participants included this 
reason in their response to the question about why they first attended. They described this 
in terms of a ‘good offer’. The way participants felt about being called can be summarised by 
the response of one participant: 
I got called and then, in my opinion, there was nothing to decide about. It was just to go there. This is 
the sort of thing, make sure to go when you get such a chance. That’s how I think. There’s nothing to 
discuss really. 
As this response started to emerge as a consistent trend, participants were asked: ‘if you 
were not called, would you attend?’ Most women replied that they would not attend unless 
they thought they had a symptom that should be investigated, for example, a lump in the 
breast. Those participants who answered that they would attend without being called drew 
on reason such as family history of or being ‘that kind of personality that likes to take 
control’. These responses illustrate how an organised and targeted program for women 
works in a policy setting where there is a high degree of trust in medical authorities. In a 
climate of trust, people are happier for those in authority to make decisions. Some women 
described themselves, and the Swedish culture, as being obeying. So if the call to be 
screened came, women did not have to think about the decision. Even the fact that they did 
not have to make the appointment time themselves was important.  
Again women’s risk perception did not really affect their decision to attend. All but four 
believed that they were at low risk of having breast cancer, although, unlike the other 
cohorts, they were more likely to acknowledge the uncertainty of risk assessment. For 
example, participants made comments such as:  
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I think I am at low, risk, but you never know. 
I don’t think I am [at risk], but you never know. My mother hasn’t got it. But of course, I could get it 
anyway’.  
Family history was perceived as being the most common indicator of high risk, so responses 
to questions about risk tended to be discussed in this way. For example, when talking about 
the links between being at low risk and family history, participants made comments such as:  
I don’t know, but not on my parents, or grandmother, nobody has breast cancer.  
No, no, in our family, we have more cervical cancer. 
When asked about the best thing about having a mammogram, participants in this cohort 
also differed slightly from the two Australian cohorts where the key response was ‘peace of 
mind that there was no breast cancer’. While the theme of ‘peace of mind’ (expressed as 
reassurance, or safety/security in this group) was identified as important, women in this 
cohort were more likely to identify that the best thing about mammography was the 
possibility of having breast cancer detected earlier, and therefore there was greater potential 
for treatment and cure’.  As the following participants said: 
You get to know if you have breast cancer. 
If something has happened you get to know it at an early stage.  
Women were asked about their awareness of the policy differences between different 
counties. The interviewer presented this difference as follows: ‘Uppsala calls women when 
they are aged 40, but Stockholm calls women when they are aged 50 – do you know why 
this might be the case?’. Sixteen participants were not aware of the debates about age and 
were quite shocked, didn’t believe that such a difference existed or were appreciative of the 
policy as enacted in their own community. Indicative responses are as follows: 
I think its crazy that they don’t have the same focus on women under 50, the earlier the better. 
I knew that everyone is called when you get 40, its all of Sweden I think. 
Oh, I didn’t know that. Then we’re really spoiled here.   
Ten participants discussed being aware that there had been some debates in the media 
about the age debate with four of these discussing that this may be because the risk of breast 
cancer increases with age, but even then comments were made such as: 
Probably you are at higher risk when you are older. I guess that’s a fact, but it can’t hurt to start 
earlier. 
This discussion was reiterated by 12 other participants who argued that the age should be 
lower, primarily because they had known someone under 50 years with breast cancer with 
some participants arguing that breast cancer was ‘spreading down in age’. Others 
mentioned that the decision must be purely based on economic reasons (9 participants) and 
were concerned that women in this age group weren’t being screened.   
5. Discussion - key ideas and policy discourses 
Sociological ideas about choice, risk and trust can shed light on the participation decisions 
that women make about attending for mammography screening. The notion of ‘choice’ is 
www.intechopen.com
 
Choice, Trust and Risk - The Policy Context and Mammography Screening  
 
19 
particularly relevant in the Australian context, because the policy for women aged 40-49 
years is predicated on individual women making the choice about whether to participate in 
screening. Here the emphasis is on women being well informed and having the capacity to 
make choice, in contrast to women aged 50-69 years where the state takes more of a role in 
facilitating their participation in screening. It is interesting to reflect on this policy emphasis 
on choice, as the state takes more of a passive role because of the much higher level of 
uncertainty about evidence of benefit, handing the decision back to individuals.  
These ideas are particularly relevant in considering the scientific and public uncertainty 
about screening in this age group, the popular discourse that the incidence of breast cancer 
is rising in this age group, and media coverage of young women’s battles with breast cancer 
(in Australia, Kylie Minogue, a celebrity figure was diagnosed with breast cancer in her 30s; 
similarly, actress Belinda Emmett died from the illness, and Jane McGrath, the wife of 
popular cricketer, Glenn McGrath, died from the illness, but has remained in the public eye 
through media coverage of her husband’s commitment to raising funds for better care of 
women with breast cancer).  
While the key themes of trust, risk and choice emerge across all three cohorts in this study 
they are differently emphasised according to the policy settings. Perceptions of risk alone 
cannot explain why different factors emerge in differing policy sectors. Alongside ‘system 
trust’ which was important in the Swedish example, there is also the emergence of 
uncertainty about age and breast cancer. This is important in the two Australian sites, but 
particularly in relation to the Victorian case. Here in the context of uncertainty women need 
to draw on a rights-based discourse in order to protect their entitlement to be screened. The 
ideas around choice and community action are particularly important in the Tasmanian 
context – they are re-invited each two years once they have decided to attend, so their 
entitlement to the service is less fragile than their Victorian counterparts, but they are aware 
of the social consequences for choosing or not choosing to use the service. The importance of 
the local service emerged as a theme across each of the settings.  
The presence of the breast screening mobile service is highly visible and the service is well 
advertised through local networks and local media, suggesting that there becomes a strong 
social encouragement among the community networks to attend while it is there. This was 
evident in both the Tasmanian and Victorian cohorts. Women were asked about what advice 
they would give to a friend and the strength of their answers was surprising with all but 
four participants in the Tasmanian cohort stating that they would actively encourage their 
friends to attend. For example, women in the Tasmania cohort said: 
Essential. As soon as someone turns 40 I tell them to go. 
Since I’ve been going for screening, I’ve been jumping on people to do that as well. 
Yes, I’d say, “Come on, we’ll go together and we’ll do lunch”. I’d encourage them. 
Location in a rural setting was linked to participation for women across all three cohorts. In 
this way, participation was screening was identified as a community action. People in rural 
centres are acutely aware that when services are provided they must use them, otherwise 
they risk losing them. As one Victorian participant stated when asked if it was important to 
use services like the mobile screening van:  
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Definitely because they’ll keep coming. We’re pretty disadvantaged with lots of things and it’s great 
to see something come and basically the idiom is if you don’t use it, you lose it, so yes, I think its 
important. 
While the perceptions of individual risk remained low, women in the study identified the 
importance of using the service provided because it may help other women. This is 
powerfully encapsulated by one of the women from the Tasmanian cohort who points to the 
fact that she decided to participate in breast cancer screening primarily for community 
reasons, not because she believed that it would benefit her personally: 
At the time the bus was very new. It was the first time it had ever come [here], and it advertised for 
women over 50. You could go as a choice thing and I thought I had absolutely no person in my family 
with breast cancer at all. But I thought if I didn’t go, and all the people didn’t go, the bus wouldn’t 
come back again. So I went really to make sure the bus would come back again. Because it mightn’t be 
me it helps, but it could be someone else. Because it costs nothing and its only a few minutes of 
inconvenience and paid... I’m positive that I will never have breast cancer. 
In Victoria, the mobile service served as a reminder for women to attend the service, in the 
absence of formal reminder letters. This was also one way that the screening staff 
encouraged women to re-attend. For example, one woman said she was told by staff that 
she wouldn’t be re-invited until she turned 50, but that the service was well advertised in 
the local area and so she would know that she was due to be rescreened because the service 
would come back in two years. So all she had to do was to phone and make an appointment. 
Additionally, in the Swedish cohort, the use of a local service was also seen as a political 
action – that of reminding decision makers that ‘we are many women here as well’, and that 
services should not be centralised. It was in this setting that women were more likely to 
state that they would not use the service if they had to travel further distances. This perhaps 
indicates that trust in authorities  is easily broken - as these women had not actively made 
the choice to participate in screening, their commitment to it was dependent on the 
provision of adequate arrangements for screening by health service authorities. 
The provision of information to this age group is problematic. The scientific disagreement 
about the efficacy for women younger than 50 years, combined with the difficulty of 
translating epidemiological knowledge to the decision making processes at the clinical or 
individual level, means that clear information provision to assist informed choice is difficult 
to achieve. Across the three cohorts, there was some knowledge that the risk of breast cancer 
increases with age, but there was also uncertainty about this and confusion about whether 
this was the case. Many women talked of younger women who had been diagnosed with 
breast cancer and this subjective knowledge was sufficient to argue that the age at which 
screening should commence should be lower. In this way, screening was presented as a 
largely unproblematic solution to the problem of breast cancer. Only a few women 
mentioned that it may not be entirely accurate.  
It has been suggested that modelling the outcomes of screening mammography can provide 
women with the information they need when deciding whether to be screened. Barrett et al 
(2005) argue that a clear statement of the risks and the benefits of screening can be modelled 
and thus provide more balanced information to women. Hersch et al (2011) problematise the 
mismatch between women’s beliefs and values and the need to ensure informed consent in 
the context of ‘widely held positive attitudes and often uncritical support for 
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mammography and sreening generally’. In a study of Canadian woman, Vahabi and 
Gastaldo (2003: 253) note that women ‘are basing their decision on incomplete information’. 
It is also claimed that ‘the messages that women are receiving about mammography are 
skewed in favor of screening’ (Silverman, et al. 2001: 239) in part because population based 
programs such as mammography require large numbers of women to participate in order to 
show efficacy. However, while the push for balanced information is important, information 
provision in itself is, I argue, insufficient as the sole source of knowledge that should be 
taken into account in the decision to be screened. Social ideas and values are likely to 
influence the way that apparently neutral information is received and acted on. This is 
where ideas about trust may be useful. With close attention to the role of trust in health care 
encounters, there must also be attention to how trust occurs in situations where the 
information is inadequate. While some theorists argue that what is required is a ‘leap of 
faith’ in such situations, others argue that trust emerges from taking account of available 
information (see, Meyer et al., 2008) – thus, those women who draw on experiential 
knowledge, knowledge of living in a rural community, and on dominant discourses about 
cancer may have incomplete epidemiological knowledge but draw the evidence that is 
available to them. It is not surprising that such evidence results in a high level of trust  in the 
technological response to cancer, through mammography, and in the health authorities who 
provide the service. This notion of trust is very different to that envisaged by some policy 
makers who may prefer to believe in the objective and rational consumer carefully 
considering how the scientific evidence will play out in an individual risk assessment. The 
policy setting cannot be divorced from such considerations. 
6. Conclusion and policy implications 
The research reported in this chapter goes some way to understanding how policy impacts 
on women’s decision to participate in breast cancer screening. This research can be 
contrasted with dominant understandings of women’s behaviour in two key ways. First, 
most research in this area focuses on why women don’t participate and aims to understand 
how best to reach ‘non-compliant’ or under-served populations. Second, research tends to 
draw on individualised models of behaviour to understand women’s decision making. This 
research aims to connect the policy context with the decisions that women make about 
participation in breast cancer screening. What is evident from the brief international review 
of selected countries is that there isn’t a clear message for women aged 40-49 years to draw 
on in their decision making. The policy advice that this should be an individual risk 
assessment decision by women themselves is at odds with all of the scientific evidence 
which is aimed at a population based approach. As clinicians well know, population based 
evidence is difficult, or impossible, to translate into a message about individual benefit. For 
women at the three policy sites investigated for the qualitative study, the different policy 
settings did affect how they understood the decision to be screened, and identified a range 
of factors that cannot be individualised – decisions about health care are made within a 
social context where dominant ideas about cancer meet health service provision. This is 
particularly relevant when considering how the impact of the social affects rural women’s 
decisions to be screened. As Pasick and Burke (2008: 358) argue, we need an understanding 
of mammography use “that is not abstracted from daily life and all its variations, our theory 
must reflect a more complex an nuanced approach to the socio-cultural and behavioural 
mechanisms involved“. 
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